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Abstract 
 
A novel integrated biosensor methodology is proposed and demonstrated. The 
methodology utilizes a nitrogen-containing plasma polymer to achieve linker-free 
binding of biorecognition molecules that allows the sensor surface to be freeze dried for 
long shelf life under ambient conditions. The sensor is configured for single wavelength 
ellipsometric detection providing a low cost, versatile, and rapid sensing and diagnosis 
platform suitable for a wide range of applications and end-users. The merits of the 
methodology were demonstrated using three antigen-antibody pairs.  
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Introduction 
 
Biosensing using a biological recognition element is the preferred approach to identify 
and quantify biologically-relevant analytes.  Suitable approaches that have been 
demonstrated using biological recognition elements include antigen-antibody 
interactions1,2, oligonucleotides3,4, lectin-glycoprotein and hormone-receptor interactions5, 
6.  In these interactions, molecular binding or detaching is quantified or sensed using a 
transducer. Proposed sensing techniques include scattering interferometry7, 
microcantilevers8, electrical impedance spectrometry9, magnetic relaxation biosensing10, 
and a variety of methods based on ellipsometry11-13.  Currently all of the techniques suffer 
from at least one of the following drawbacks: lengthy and complex processing for the 
preparation of linkers to provide robust immobilization of the initial biological 
recognition layer, non-specific interactions, a short shelf life of pre-prepared sensors, and 
the lack of a convenient, reliable and rapid diagnosis method14, 15.  Clearly, an integrated 
solution is needed that brings together in the sensor design, simple and universal 
immobilization, storage shelf life and simple diagnosis methodology. 
 
Covalent immobilization of the biomolecular recognition element is preferred, as 
physically bound biomolecules can be detached during use and often are destabilized by 
the physical interactions that immobilize them to the surface. Covalent binding is usually 
achieved with by employing linker groups, which require specialized and complex 
chemical procedures to prepare them on the surface, and are often not able to retain the 
activity of the bound molecule over a practically useful time16-18. A simple approach that 
is effective across a broad range of molecules has been recently developed using a thin 
layer of nitrogen-containing plasma polymer (NPP) to covalently capture protein from 
solution to immobilize an almost fully dense monolayer of covalent bound, demonstrated 
using a wide range of proteins and various analysis methodologies19-24.  Direct evidence 
for the covalent binding capability of these plasma polymers has been revealed by a shift 
in the chemical binding energy of the sulfur in cysteine amino groups22.  The mechanism 
of the covalent binding of proteins onto the NPP has been attributed to accessible 
radicals23, 24.   The covalent binding ability of the NPP was found to last for at least a year 
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and can be regenerated by annealing in vacuum19. The properties of the NPP were 
characterized previously using the techniques of atomic force microscopy, attenuated 
total reflection Fourier transform infrared spectrometry, electron paramagnetic resonance, 
XPS, FTIR, AFM, and surface energy analysis19-24. The protein covalent immobilization 
capability of the NPP plasma polymer was demonstrated using a number of common 
proteins19-21, including horseradish peroxidase, human tropoelastin, catalase, and 
microperoxidase-11.  
 
In this study, we integrate the covalent binding capacity into a complete biosensor 
methodology in which the recognition proteins are immobilized covalently, followed by 
freeze-drying to retain their activity during shelf storage. The readout technique we 
develop in this work is single wavelength, fixed incident angle ellipsometry with 
optimized sensitivity13, 25-27.   The advantage of this approach is that the end-users do not 
need to carry out complex sensor preparation which compromises repeatability and 
reliability.   
 
Results 
 
Sensing optimization 
The concept of our biosensor methodology using ellipsometry is illustrated in figure 1.  
In Fig.1a, spectra for the ellipsometric parameter Psi are calculated for 3 example sensors 
with different thicknesses of the NPP layer on a 150 nm silicon nitride coated silicon 
wafer support.  The sensors are assumed to be in a water ambient with sensing radiation 
inclined at an incidence angle of 70o.  The positions of the valleys in the spectra 
correspond to the wavelengths that give a pseudo-Brewster angle of 70o. The sensitivity, 
shown by the change in Psi caused by adding a 1.0 nm thick protein layer of refractive 
index of 1.46, is plotted in Fig 1b. The sensitivity near the valley is low and varies 
significantly ; therefore, it is necessary to choose the NPP thickness to avoid locating the 
valley of the Psi spectrum near the 632 nm sensing wavelength. The sensitivity is high 
and stable for wavelengths that are far well away from the valley. For comparison, the 
sensitivity (the change of Psi) of a conventional silicon sensor with a self-assembled 
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monolayer linker layer of 1.0 nm thickness is also shown (Fig 1b). These results show 
that with an appropriately designed sensor structure, the sensitivity of the sensor can be 
made much higher than for a silicon sensor with a conventional self-assembled 
monolayer as a linker.  Figure 1c shows the flow chart of the proposed biosensor 
methodology using the antigen-antibody interaction as an example: design and construct 
a biosensor according to the principle shown in Fig.1a and Fig.1b with an NPP top layer; 
covalently immobilize antigen on the biosensor (as in immnosensor); carry out a freeze-
drying treatment; store the freeze-dried sensors in dry air; and finally, when needed, use 
the sensor for diagnosis.     
 
Linker-free covalent immobilization of proteins on plasma polymers 
Figure 2 shows some of the examples of linker free protein covalent binding on NPP 
surfaces and compares them with reference surfaces.  Some technical information is 
provided in SI and illustrated in the Fig.S1-S4. The covalent binding of the proteins to the 
surfaces was verified by its persistence when exposed to rigorous washing in SDS 
detergent.  In Fig.2a, we show the XPS analysis data of human tropoelastin on NPP 
compared with bare silicon and diamond-like carbon (DLC).  In the XPS analysis, the S 
2p peak was used instead of the N 1s peak as the nitrogen peak has a major contribution 
from the NPP.  The XPS S 2p peak arises from cysteine or methionine amino groups in 
the proteins. Rinsing in water after SDS treatment removes almost all SDS molecules.  
Any trace or small quantity of remaining unwashed SDS on surfaces can subtracted from 
the S 2p peak as the binding energy of S 2p in SDS is approximately 4-5 eV larger than 
that of the main S 2p peak of proteins. This method was recommended previously for 
XPS analysis of immobilized proteins on surfaces containing nitrogen and the results 
correlated very well with ELISA analysis23. The covalent binding capacity (vertical axis 
in Fig 2a) is defined as the ratio of the remaining tropoelastin after SDS cleaning to the 
protein quantity before SDS treatment. A significantly higher covalent binding capacity 
of the NPP surface was evident.  The DLC surface has been previously proposed for 
biosensor applications, for example, by Hartl et al28.  The significantly higher covalent 
protein binding capacity of NPP suggests that the NPP surfaces are more suitable for 
biosensor applications.  Fig.2b shows the ellipsometry analysis of catalase on NPP in 
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buffer with the sequence: without protein (NPP), after incubation in catalase protein 
solution followed by rinsing with fresh buffer (Cata), after 0.2% SDS treatment without 
water rinse (SDS), and after rinsing with deionised water (Rinse).  Figure 2c shows the 
quartz crystal microbalance with dissipation (QCMD) analysis of horseradish peroxidase 
(HRP) on a NPP surface with the sequence: HRP immobilization from solution (HRP), 
PBS rinse (buffer), 2% SDS cleaning (SDS), then PBS rinse again.  The bound mass after 
SDS treatment and PBS rinse was about 300 ng/cm2, which is approximately equal to a 
monolayer of HRP.  After introducing SDS, the mass increased initially to approximately 
twice the mass of the initially immobilized proteins, followed by a steady reduction of the 
mass.  Protein collagen 1 was also analysed using QCMD as shown in Fig.S6 of 
Supplementary Information (SI), showing a similar result.  The ellipsometry result in 
Fig.2b was also confirmed using XPS analysis, as shown in Fig.S7 of SI.   
 
Figure 2d shows XPS analysis of BMP-7 (human bone morphogenic protein-7) remaining 
after SDS cleaning using the same analysis method as for Fig.2a. Three surfaces were 
compared: bare PDMS, plasma polymer without nitrogen (PP), and NPP.  The PDMS had 
negligible covalent binding capacity, the plasma polymer (PP) that contained no nitrogen 
had a lower covalent binding capacity for the BMP-7 protein than NPP, consistent with 
previous observations using other proteins23. The high coverage of the covalent or strong 
binding of the proteins on the NPP surfaces provides a straightforward and reliable 
platform for biosensor applications29-31.   
 
Table 1 summarizes the proteins used and the method adopted for a range of  covalent 
binding studies together with the covalent binding coverage observed on the NPP 
surfaces. The high covalent binding capacity for a variety of proteins on the NPP surfaces 
is attributed to a high density of highly reactive radicals contained within the NPP 
surfaces22.   
 
Freeze-drying effect on protein binding  
In the freeze-drying treatment, sucrose was used in the last step as a stabilizer.  Sucrose 
and other sugars have been used successfully to stabilize freeze-dried non-immobilized 
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proteins32, 33 and linker layers34 and to retain the activity of freeze-dried HRP 
immobilized on ion implantation treated polymers35.  Figure 3a shows the activity as a 
function of the number of days of rocking in buffer for HRP immobilized on NPP 
surfaces before freeze-drying (FD-before), after freeze-drying (FD-after) and for HRP 
immobilized on silicon surfaces (Si) without freeze-drying.  Immediately after freeze-
drying, the HRP immobilized on NPP had a comparable activity to that before freeze-
drying and much higher than its activity on silicon without freeze drying.  After 5 and 10 
days of rocking in buffer, the activity of the enzymes with and without freeze-drying on 
NPP was still high compared with silicon.  The enhanced activity and the ability to 
withstand prolonged buffer rocking was attributed to covalent binding in a native 
conformation, implying that the freeze-drying process did not change significantly the 
conformation status of the immobilized proteins on NPP.  This may be due to multipoint 
covalent attachment of HRP proteins on the NPP.  It has been suggested that multipoint 
covalent binding can result in a more rigid conformation of immobilized proteins35, 36.   
 
Figure 3b shows the conformational status of anti-HRP immobilized and freeze dried on 
NPP surfaces. The plot shows the time required for the anti-HRP to achieve a binding of 
an approximate monolayer of HRP as a function of HRP concentration. The results show 
that the anti-HRP remains functional and is capable of binding HRP at very low 
concentrations of HRP, of less than 1ng/ml. In Fig.3c, we show the activity of the 
immobilized HRP as a function of storage time after freeze drying.  Storage was 
performed in dry air in a desiccator with ambient temperature in the range between 10 
and 20oC (Australia Sydney autumn-winter season, temperature capped at 20oC using 
cooling-only air-conditioning).  The result indicates that using the freeze-drying method, 
the enzyme immobilized NPP biosensors can be stored at room temperature under dry 
conditions for a long period of time, convenient for storage and transportation without 
refrigeration.  If refrigerated storage is used, it is expected that an even longer lifetime of 
immobilized dried proteins is possible34, 37. The freeze-drying did not alter the covalent 
binding nature of the proteins on the NPP surfaces as shown in Fig.3d, in which four 
proteins were analysed using XPS including HRP, anti-IgG, anti-HRP, and human 
tropoelastin.  The covalent binding capacities assessed after freeze-drying treatment are 
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similar to those shown in Table 1 without freeze-drying treatment.  This is expected as 
once a protein is covalently bound to a surface, it should be stable under conditions 
encountered in the freeze-drying treatment unless the surface itself is unstable.  In 
contrast, in the case of silicon surfaces with self-assembled monolayer linkers, the silicon 
can gradually oxidize and release the bound self-assembled monolayer linker38, 39.   
 
Nitrogen-containing plasma polymer biosensors without freeze-drying treatment  
The performance of the biosensors was first analysed without introducing the freeze-
drying treatment.   In the following, we demonstrate experimentally the high sensitivity 
achievable with ellipsometry that was predicted theoretically above. Figure 4 shows a 
range of protein interactions using both ellipsometry and XPS methods for sensing. 
Figure 4a and Fig.4b show the measurements obtained over the sequence of operations: 
before protein immobilization, after incubation in 200 μg/ml anti human IgG buffer 
solution and subsequent rinsing in buffer (Anti-IgG), followed by blocking in 1 mg/ml 
BSA and rinsing in buffer (BSA), then after soaking in 200 μg/ml human antibody and 
rinsing in buffer (IgG).  The biosensor in Fig.4a-b was constructed to place the spectral 
valley in Psi (the wavelength corresponding to the pseudo-Brewster angle of 70o) close to 
632 nm.  As shown in the discussion relating to Figure 1a-b, this is a case where the 
minimum in Psi lies close to the sensing wavelength of 632nm and therefore a 
measurement of Psi at this wavelength cannot be used for the biosensor readout. 
Although the changes in the parameter Del near 632nm were large, they were not 
uniform with wavelength. This means that single wavelength ellipsometry at 632nm 
cannot be used for reliably quantifying the protein interactions. Note that the BSA 
blocking after anti-IgG immobilization did not introduce significant additional shifts in 
either Psi or Del. This is interpreted as the initial anti-IgG immobilization on the NPP 
surface resulting in a dense covalently bound monolayer, in a good agreement with the 
results shown in Fig.2 and reported previously19-24.   
 
Figure 4c shows the Psi spectra for a correctly constructed biosensor for sensing at 
632nm. Figure 4c shows measurements obtained over the sequence of operations: before 
protein immobilization (NPP), after incubation in 50 μg/ml HRP buffer and subsequent 
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rinsing in buffer (HRP), followed by incubation in 4 μg/ml anti-HRP buffer and rinsing 
in buffer (HRP+antiHRP), and then further incubation in 100 μg/ml HRP buffer and 
rinsing in buffer (HRP+antiHRP+HRP).  The resulting changes in Psi are: HRP binding 
(0.43o), anti-HRP binding (0.80o), and no change for further HRP exposure.  Since the 
typical angle sensitivity of a low cost ellipsometry system is better than 0.02o, this result 
suggests that the NPP sensor provides reliable analysis. Using a simple linear relationship 
between the immobilized protein layer thickness and the change of Psi, we can calculate 
that the molecular ratio of the anti-HRP to initially bound HRP is 1:1.5. This indicates 
that the anti-HRP captured by the initial immobilized HRP also had a high density.  
Further incubation in HRP (to give the layer structure HRP+antiHRP+HRP) did not alter 
the reading. The XPS analysis on the anti-HRP biosensor agreed reasonably well with the 
ellipsometry data in Fig.4c which gave a value of 1.86 for the immobilized protein 
quantity ratio of the anti-HRP to the HRP as shown in Fig.4d.  The shoulder in the C1s 
spectra near 288.5eV are commonly used for approximate quantification of immobilized 
proteins40.  The integrated intensity ratio in the range of the shoulder for the increment 
due to additional anti-HRP immobilization to that due to the HRP immobilization was 2.0, 
which was the approximately the same ratio as that obtained using the corresponding S 
2p peaks in the XPS analysis.  Considering the fact that in the XPS analysis, a thicker 
protein surface layer would be slightly over-counted due to the higher sensitivity for the 
top layer41 unless only one monolayer layer of proteins is immobilized23, this is 
considered good agreement.    
 
In Fig.4e, we show another NPP biosensor using human tropoelastin and anti-tropoelastin 
and the ellipsometry method for sensor readout (the corresponding spectra were shown in 
Fig.S9 of SI).  The Psi readings at 632 nm shown in Fig.4e are for the following sequence 
of conditions: before protein immobilization (NPP), after incubation in 20 μg/ml anti 
human tropoelastin and rinsing in buffer (Anti-tropo), followed by incubation in 5 μg/ml 
human tropoelastin and rinsing in buffer (Tropo).   The corresponding ellipsometry 
spectra for Fig.4e are shown in Fig.S9 of the SI.  The sensitivity for both the anti-
tropoelastin and tropoelastin was good, and was smaller than the measurement 
uncertainty.   
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In Fig.4f we show the XPS C1s spectra of a NPP biosensor for the following sequence of 
conditions: before protein immobilization (NPP), after incubation in 20 μg/ml protein-A 
and rinsing in buffer (PA), and then incubation in 50 μg/ml human IgG and rinsing in 
buffer (PA+IgG). Protein-A is widely used in biosensors to orient antibodies42. The same 
type of NPP biosensor was also analysed using the ellipsometry method for the same 
sample sensing conditions.  The values of Psi at 632 nm are given in the inset to Fig.4f.    
Protein-A can accommodate the Fc site of an IgG molecule to leave the Fab sites 
available for antigen binding reactions.  The changes in Psi resulting from the protein 
immobilization are 0.21o and 0.35o for protein-A and human IgG respectively.  Using 
XPS C 1s analysis, the mass ratio of the immobilized IgG to the protein-A was found to 
be about 1.64, which agrees well with the ratio 1.66 determined using the ellipsometry 
method.  The XPS and ellipsometry analysis shown in Fig.4f suggests that approximately 
every two immobilized protein-A proteins can capture one IgG protein, giving 
approximately a 50% capture efficiency. Considering the larger size of an IgG compared 
to protein-A, this IgG capture efficiency of the immobilized protein-A is excellent, and it 
is consistent with the random model of protein adsorption and shows that almost all IgG 
molecules are correctly oriented. 
 
Freeze-dried nitrogen-containing plasma polymer biosensors  
The sensitivity of the freeze-dried NPP biosensors using ellipsometric readout at 632nm 
is shown in Figure 5.  All the freeze-dried NPP biosensors had storage conditions similar 
to that for Fig.3c with a storage period between one week and two months.  The 
corresponding spectra of Fig.5a-e are shown in Fig.S10 of SI.  Figure 5a shows a NPP 
biosensor for human IgG measured over the sequence of operations: incubation in 20 
μg/ml anti-IgG followed by freeze-drying (Anti-IgG+FD), incubation in 1mg/ml BSA 
blocking (BSA), and the incubation in 10 μg/ml human IgG.  After BSA blocking, the 
reaction with human IgG resulted in a change of Psi approximately 25 times larger than 
the change from the BSA blocking, demonstrating a high sensitivity of the NPP IgG 
biosensor.  
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In Fig.5b we show the operation of a freeze dried protein A biosensor.  The sequence of 
conditions was: protein-A immobilized and freeze dried (PA+FD), 40 μg/ml anti-
tropoelastin immobilization (Anti-tropo), 1 mg/ml BSA blocking (BSA), and 40 μg/ml 
human tropoelastin immobilization (Tropo).  As shown in the Figure, the freeze dried 
biosensor can be functionalised with Anti-tropoelastin and is capable of detecting 
Tropelastin in solution. Figure 5c shows results for a similar freeze-dried protein-A 
immobilized NPP biosensor for the human IgG and anti-IgG reaction. The following 
sequence of operations was used：protein-A immobilization and freeze-drying (PA+FD), 
20 μg/ml human IgG immobilization (IgG), 1mg/ml BSA blocking (BSA), 1 μg/ml anti-
IgG immobilization (Anti-IgG), and further 20 μg/ml human IgG immobilization (IgG+).  
The first IgG immobilization resulted a large increment of Psi, indicating the excellent 
efficiency of the capturing ability of the immobilized and freeze-dried protein-A on the 
NPP biosensor.  The large anti-IgG immobilization increment shows that the function of 
the IgG is preserved during the immobilization. The stability of the triple-layer of 
proteins (Protein A+IgG + antiIgG) was challenged by a further soaking in 20 μg/ml 
human IgG buffer (IgG+) fro 30 min.  There was only a small decrease of Psi indicating 
that the triple-layer was stable. 
 
The effectiveness of the freeze-drying was further analysed using a NPP biosensor which 
was processed with protein-A immobilization and then human IgG soaking prior to the 
freeze-drying treatment.  In Fig.5d, we show the response of the biosensor in the analysis 
with the sequence of operations：after protein-A and human IgG immobilization then 
freeze-drying treatment (PA+IgG+FD), 1 mg/ml BSA blocking (BSA), then 10 μg/ml 
antiIgG immobilization (Anti-IgG). The biological responses of this biosensor were 
similar to those in Fig.5a-c. Such freeze-dried protein double-layer biosensors provide an 
opportunity for a wide range of end-users and applications and will have a particular 
advantage when rare antigen (or antibody) biosensors are required in medical diagnosis.  
In Fig.5e we show a HRP immobilized biosensor with the sequence of operations：after 
HRP immobilization and freeze-drying treatment (HRP+FD), 1 mg/ml BSA blocking 
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(BSA), then 4 μg/ml anti-HRP immobilization (Anti-HRP). The biological responses of 
the anti-HRP biosensor were consistent with the performance of other biosensors 
described above (Fig.5a-d). Figure 5f is an example of a time trace of Psi for an anti-HRP 
biosensor, showing the response of the anti-HRP immobilization. After approximately 30 
minutes, the antigen-antibody reaction was sufficient for the Psi signal to stabilize in a 
conveniently short time even when a low (0.2 μg/ml) concentration of anti-HRP was used. 
 
Discussion and conclusions 
 
We have demonstrated in this paper an integrated solution for biosensing. The 
methodology we have demonstrated is reliable, rapid, and the end-user will find it easy to 
use. The reliability of the biosensors results from the high covalent binding capacity of 
the NPP surfaces for protein and the excellent performance of the biosensors after a 
freeze-drying treatment.  The rapidity and the end-user convenience are attributed to the 
optimized biosensor optical design, the simplicity of the diagnosis method, and the 
simple storage procedure, enabling minimal involvement at the diagnosis step, especially 
for those not having specific biosensor formation facilities and skills.  XPS and QCMD 
were used to confirm the covalent binding nature of the NPP surface before and after the 
freeze-drying treatment.  The antigen-antibody interactions on the NPP biosensors were 
comprehensively reconfirmed after freeze drying using the XPS technique.   
 
Three different pairs of antigen-antibodies, together with protein-A to accommodate 
different antibodies, were tested to demonstrate the new biosensor methodology.  It is 
apparent that this method is suited for not only immunosensors but also for other types of 
biosensors as long as the biological reactions result in mass change or involve molecular 
binding/detaching processes on the surface of the biosensor.  The high sensitivity of the 
biosensors using the antigen-antibody interactions was demonstrated consistently for 
cases with and without freeze-drying treatment.  Protien-A after covalent immobilization 
remained functional for the cases: protein-A only with and without freeze-drying 
treatment, and antibody on protein-A with freeze-drying treatment.  BSA blocking 
showed very little changes of sensor readings, compared to those resulting from the 
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antigen-antibody interactions, indicating a high density of covalently immobilized 
functional protein for all cases with or without freeze-drying treatment.  Using anti-HRP 
biosensors for consistency analysis, we found the ratio of sensing signal to BSA blocking 
signal was basically higher than ten, and the signal induced by BSA blocking was almost 
all within system errors (showing in Figure S11 of SI). 
 
The ellipsometry Psi signal ratios of antibody to antigen in the biosensor diagnosis were 
consistent with dense layers of antibody or antigen captured or immobilized, as shown in 
Fig.4a, 4c, 4e-f, and Fig.5b-c.  The uniform response in a wide range of wavelengths, in 
the vicinity of aimed single wavelength 632 nm proves that the biosensor sensitivity can 
be controlled with minimal influence from variations in NPP thickness, providing a 
convenience approach for formation of standardized biosensors.   
 
The typical data collection time for ellipsometry analysis (single wavelength and single 
biological reaction step) for each biosensor is expected to be within a few minutes in 
most cases. Most of the processing time in the biosensor diagnosis in the ellipsometry 
method is the time required for the biological reaction to stabilise or complete, which is 
approximately one hour.  This means in the biosensor applications the bottle-neck to limit 
the biosensor diagnosis throughput is not the data collection.  Using the standardization 
of the NPP biosensors, a fast throughput of biosensor diagnosis can be achieved by 
rapidly rotating biosensors through a simple ellipsometry analysis unit while waiting for 
the biological reactions to complete.  This can offer a convenient and low cost solution 
for matching the speed advantage of integrated diagnosis techniques such as imaging 
ellipsometry43, 44, which however is disadvantaged with its high cost and complication in 
data analysis.  In addition, as the NPP biosensor process and properties were found to be 
compatible with the standard CMOS semiconductor integrated device technology19, the 
NPP biosensor methodology thus can be also used for integrated and miniature 
biosensors whenever this becomes necessary.  
 
The reasons for the high covalent protein binding capacity of the NPP surfaces compared 
with the DLC surfaces were investigated.  The covalent protein binding effect of plasma 
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polymers or plasma modified polymers was recently proposed and demonstrated 
experimentally to result from not only the areal density of radicals in the surfaces but also 
the mobility of the radicals24.  The radical density of the DLC surfaces was found using 
EPR to be similar to that of the NPP surfaces.  Thus the lower covalent protein binding 
capacity of the DLC surfaces could result from its significantly lower radical mobility as 
suggested in the EPR analysis, which is consistent with the one-dimensional quantum 
well model in our theoretical simulation for the radical transportation and protein 
covalent binding enhancement (Fig.S12 of SI) 
 
In summary, an integrated solution for a versatile biosensor technology has been 
demonstrated with the desirable features of long shelf life, simple storage procedure, 
reliable performance and minimal involvement of end-users.  The technology combines 
the high protein covalent binding capacity of NPP surfaces with a high sensitivity, low 
cost diagnosis method that shows robust performance after freeze-drying.  The covalent 
binding mechanism of the NPP surface was investigated by EPR spectroscopy. A model 
in which mobile electron spins are responsible for both the EPR signal and the covalent 
binding was confirmed. The merits of the technology were demonstrated experimentally 
using three antigen-antibody pairs.  
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Methods 
 
Plasma polymer deposition 
The plasma polymer method and system was reported previously19, 45.  The schematic 
diagram of the system is given in the supplementary materials (Fig.S1).  Briefly, the NPP 
deposition system included two plasma sources: one radio frequency (RF) electrode at 
13.56 MHz operated at 120 W to generate background plasma; the other one was a 
substrate holder connected to a pulse voltage source at 200V with pulse length 10 μs and 
repetition 10 kHz.  Gases injected into the plasma chamber were acetylene (10 sccm), 
nitrogen (4 sccm), and argon (4 sccm).   Pressure of the system was maintained at 20 Pa.   
During NPP deposition, the substrate temperature was uncontrolled and lower than 
approximately 60oC. 
 
Freeze-drying method for end-user ready biosensors 
The freezing-drying method adopted in this work was similar to that reported by 
Nosworthy et al37, 2.5% sucrose in buffer was added prior to freezing to stabilize the 
immobilized proteins. The procedure in this work was: first the protein immobilized 
plasma polymer surfaces were rinsed and transferred to Falcon tubes containing 2.5% 
sucrose in PBS buffer, each tube contained one NPP biosensor with 2 ml the sucrose 
containing buffer, then the tubes were placed into liquid nitrogen and the samples were 
frozen. Once frozen, the samples were transferred to a drying chamber (a Christ Alpha 2-
4 LDplus freeze dryer) with 0.3 mbar pressure for 48 hours until the drying process was 
completed. The samples were then stored in a desiccant with Sigma silica drying agent. 
The desiccated samples were stored at room temperature capped at 20oC with a non-
heating air conditioning during the autumn-winter seasons at Sydney, Australia (5-25oC). 
 
Materials and bio-assays 
Proteins tested and chemicals used were all purchased from Sigma without further 
purification except human tropoelastin, including horseradish peroxidase (Cat No P6782), 
bovine liver catalase (Cat No C3155), calf skin collagen 1 (Cat No C9791), 
Microperoxidase-11 (Cat No M6756), BMP 7 (Cat No B1434), human serum IgG (Cat 
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No I4506), anti-human IgG (Cat No I3266), protein-A (Cat No P1406), HRP antibody 
(Cat No P7899).  Human (recombinant) tropoelastin corresponding to amino acid 
residues 27–724 of GenBank entry AAC98394 (gi 182020) was expressed and purified as 
previously described46, tetramethylbenzidine (TMB, 3,3′,5,5′ tetramethylbenzidine, Cat 
No T0440), and anti-elastin (called anti-tropoelastin in the text)) clone BA-4 antibody 
(Cat No E4013).  
 
The procedure for HRP attachment and activity analysis is as follows unless specified in 
the text.  Samples were incubated for 20 hours in HRP (50 μg/ml) in 10 mM phosphate 
buffer (PB) at pH 7.0. Incubations were in 75 mm sterile Petri dishes with rocking.  After 
the incubation, the samples were washed 6 times each for 20 minutes in 10 mM 
phosphate buffer pH 7.0. The first wash was performed in the Petri dish used for enzyme 
incubations. Then the samples were transferred to a clean Petri dish for the next 5 washes. 
Active HRP on the surfaces of the samples was measured by clamping the sample 
(approx 15x15 mm) between two stainless plates separated by an O-ring (inner diameter 
8.0 mm, outer diameter 11.0 mm) that sealed the surface. The top plate contained a 5.0 
mm diameter hole enabling the addition of 75 μl of the HRP enzyme substrate, TMB. 
After 30 seconds (or the duration specified in the text), 25 μl of reacted TMB was taken 
and added to 50 μl of 2 M hydrochloric acid to stop the reaction. A further 25 μl of 
unreacted TMB was then added to bring the volume to 100 μl. The absorbance of the 
solution at 450 nm was then measured using a Beckman DU530 Life Science UV/VIS 
spectrophotometer. All enzyme activity tests including rocking time were performed at 
23+1oC. SDS cleaning in XPS analysis to remove physically immobilised proteins was 
carried out using 2% SDS in Milli-Q water and rocking for 4 hours at 70oC followed by 
rinsing in water for 5 times each 5 minutes.  SDS cleaning in ellipsometry analysis was 
conducted at room temperature with the procedure specified in the text and 
supplementary materials. 
 
Biosensor diagnosis methods 
The NPP biosensors were characterized using J.A. Woollam M-2000 spectroscopic 
ellipsometry, which allows us to obtain complete information in a wide range of 
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wavelengths, including wavelength at 632 nm.  The ellipsometry system is with typical 
sensitivity and accuracy (+0.01o for Psi) and has been demonstrated its effectiveness in 
many analysis27, 47, 48.  A flow cell with 70o incidence angle windows was used during the 
ellipsometry analysis.  All ellipsometry analysis was done at 70o incident angle.  Soaking 
for protein immobilization or interaction was all conducted for 30 minutes unless 
specified in the text. A photoelectron spectroscopy (XPS) system, (model: SPECS-XPS, 
from SPECS, Germany) was used to analyze the element concentration and binding 
energies of the plasma polymer surfaces.  The XPS system was equipped with a high 
sensitivity PHOIBOS 150-9 MCD energy analyzer, capable of detecting medium 
sensitivity elements to a trace level in an order of 100ppm.  Al K-alpha X-ray source 
(1486.74eV) was used in the analysis.  
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Figure captions 
 
Figure 1: (a) the ellipsometry spectra of Psi for sensors with different NPP  
layer thickness, (b) the sensitivity, or the change of Psi by 1 nm thick proteins, 
for the sensors in (a) as a function of wavelength, together for a silicon sensor 
with an 1nm thick self-assembled monolayer linker, (c) the flow chart of the 
sensing methodology using antigen-antibody as the example: design and 
formation of a base sensor with activated polymer surface; attach antigen; 
freeze-dry; store in dry air; then use by end-user for diagnosis.   
  
Figure 2: Analysis of covalent binding of proteins determined using SDS 
detergent washing, (a) XPS analysis of human tropoelastin on bare silicon, 
diamond-like carbon (DLC), and nitrogen-containing plasma polymer (NPP); 
(b) ellipsometry analysis of catalase on NPP in buffer with a sequence of 
without protein (NPP), after protein and then rinse (Cata), 0.2% SDS without 
rinse (SDS), after rinse (Rinse), (c) QCMD analysis of HRP on NPP surface, 
(d) XPS analysis of remaining BMP-7 after SDS cleaning on bare PDMS, 
plasma polymer without nitrogen (PP), and NPP, quantified using S 2p peaks. 
 
Figure 3: The effect of freeze-dry on the conformation of the immobilized 
proteins and protein binding strength, (a) the activity of immobilized HRP as 
a function of time in PB buffer for surfaces of silicon without freeze-drying 
(Si), NPP without freeze-drying (FD-before), and NPP with freeze-dry after 
HRP immobilization (FD-after); (b) the time required for activity to reach 0.5 
for immobilized HRP onto anti-HRP attached and freeze-dried NPP surfaces  
as a function of HRP concentration, showing the freeze-dried and 
immobilized anti-HRP biosensors were highly sensitive to a small trace of 
HRP in buffer; (c) the retained activity of immobilized HRP on NPP for 
conditions of without freeze-dry (No FD), immediately after  freeze-dry (FD 
0 day), and three months after freeze-dry (FD 3 months); (d) covalent binding 
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capacity for four examples of proteins immobilized onto NPP surfaces after 
freeze-dry process and analyzed using XPS. 
 
Figure 4: Applications of the proposed biosensors for different antigen-
antibody interactions using the ellipsometry and XPS diagnosis methods, (a) 
and (b) elipsometry spectra of Psi and Del respectively in the range near 
632nm for sequential conditions: before protein immobilization on NPP 
(NPP), after anti human IgG soaking in 200 μg/ml buffer and rinse (Anti-IgG), 
followed by soaking in 1mg/ml BSA solution (BSA), then soaking in 200 
μg/ml human antibody (IgG); (c) ellipsometry Psi spectra and (d) XPS C 1s 
spectra for biosensors before protein immobilization (NPP), soaking  in 50 
μg/ml HRP buffer (HRP), after 4 μg/ml anti-HRP buffer (HRP+antiHRP); 
then further soaking in 100 μg/ml HRP buffer and rinse 
(HRP+antiHRP+HRP); (e) the Psi readings at 632 nm for a biosensor at 
conditions: no protein immobilization (NPP), after 20 μg/ml anti human 
tropoelastin immobilization and rinse (Anti-tropo), and then after 50μg/ml 
human tropoelastin immobilization and rinse (Tropo); (f) XPS C 1s spectra of 
biosensors for conditions: before protein immobilization (NPP), after 20μg/ml 
protein-A immobilization and rinse (PA), and then further 50 μg/ml human 
IgG soaking and rinse (PA+IgG), the values of Psi in the legends’ brackets 
are the ellipsometry analysis data for the same conditions at 632 nm 
wavelength.  
 
Figure 5: Examples of biosensors with freeze-drying treatment using 
ellipsometry analysis (note all steps from (a) to (e) had buffer rinse). (a) a 
human IgG biosensor on anti-IgG immobilized biosensor with a sequence of 
after anti-IgG immobilization and freeze-dry (Anti-IgG+FD), BSA blocking 
(BSA), and human IgG immobilization; (b) a protein-A immobilized 
biosensor with a sequence of after protein-A immobilization and freeze-dry 
treatment (PA+FD), anti-tropoelastin immobilization (Anti-tropo), BSA 
blocking (BSA), and human tropoelastin immobilization (Tropo); (c) a 
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protein-A immobilized biosensor with a sequence of after protein-A 
immobilization and freeze-dry treatment (PA+FD), human IgG 
immobilization (IgG), BSA blocking (BSA), anti-IgG immobilization (Anti-
IgG), and further human IgG immobilization (IgG+); (d) a protein-A then 
human IgG immobilized biosensor with a sequence of after protein-A and 
human IgG immobilization then freeze-dry treatment (PA+IgG+FD), BSA 
blocking (BSA), then antiIgG immobilization (Anti-IgG); (e) a HRP 
immobilized biosensor with a sequence of after HRP immobilization and 
freeze-dry treatment (HRP+FD), BSA blocking (BSA), then anti-HRP 
immobilization (Anti-HRP); (f) a time trace of Psi at 632 nm for an anti-HRP 
biosensor, showing the response of the anti-HRP immobilization. 
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Figures and Tables 
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Figure 5 
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Table 1: Covalent binding coverage of a variety of proteins on the NPP surfaces using 
different analysis methods, the sign of * indicates the test was reported previously in 
references 19-23. 
 
Protein Methodology Covalent coverage 
human tropoelastin XPS*, QCMD*, ELISA* >75% 
bovine liver catalase XPS*, QCMD*, Ellipsometry >75% 
horseradish peroxidase XPS*, QCMD*, Ellipsometry >75% 
microperoxidase-11 XPS* >80% 
bone morphogenic protein-7 XPS >75% 
calf collagen 1 Ellipsometry, QCMD, XPS >80% 
Anti human IgG XPS, Ellipsometry >75% 
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